Comparison of the Outcome of Treatment With Silymarin or N-Aceylcysteine in Patients Taking Anti-Tuberculous Drugs for Tuberculosis at a Tertiary Care Hospital , Karachi

NCT07058090 · clinicaltrials.gov ↗

PHASE1

Phase

NOT_YET_RECRUITING

Status

410

Enrollment

OTHER

Sponsor class

Conditions

Drug Induced Liver Injury
Tuberculosis (TB)

Interventions

DRUG: Silymarin 420 mg
DRUG: N Acetyl Cysteine
DRUG: Rifampicin (RMP) Ethambutol (E) Isoniazid (H) Pyrazinamid (Z)

Sponsor

Liaquat National Hospital & Medical College